In 2023, the diuretic medicine market in Türkiye stood at 43.3 million USD, showing a year-on-year growth of 5.35%. This marks a steady increase from recent years, with a noteworthy compound annual growth rate (CAGR) of 16.47% over the past five years. From 2013 to 2018, the market exhibited volatility, including declines in 2015 and 2018. Post-2018, the market saw significant growth, particularly between 2019 and 2021, peaking in 2020 with a 25.36% increase. From 2024 onward, the forecast suggests a more moderate CAGR of 1.8% over the next five years, implying slower, yet steady growth.
Future trends to watch for:
- Potential impacts of new healthcare policies in Türkiye.
- Technological advancements in drug formulations.
- Demographic shifts and the aging population's growing demand for diuretics.
- Possible market disruptions from emerging competitors and generic drugs.
